COOK G47451Recalls & reported problems
William Cook Europe ApS · Zenith TX2, Dissection Endovascular Graft with Pro-form, and the Z-Trak Plus Introduction System-Straight Component · Class 3 · Implant
All models of COOK (26)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 10827002474519), received between Jan 27, 2022 and Feb 15, 2022 — classified as 2 injuries.
The most frequently reported specific device problem is “Physical Resistance/Sticking” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Physical Resistance/Sticking2
Patient problems
- Hemorrhage/Blood Loss/Bleeding2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryFeb 15, 2022Physical Resistance/Sticking; Physical Resistance/Sticking
DESCRIPTION OF EVENT ACCORDING TO THE INITIAL REPORTER: PT CAME IN EMERGENTLY DUE TO RUPTURE. (B)(6) (B)(6) 2022 ((B)(4)) THE FIRST DEVICE (G47452, LOT E4201640) DID NOT LAND IN THE RIGHT PLACE DUE TO OPERATOR ERROR. A LACK OF UPWARD FORCE IN HOLDING THE DEVICE INTO POSITION CAUSED THE PROBLEM. ON ((B)(6)) THEY HAD TO USE SECOND DEVICE (G47451, LOT E4202793) BECAUSE THE FIRST DEVICE WAS NOT IN THE PROPER PLACE. WHEN THEY TRIED TO USE THE SECOND DEVICE, THE TRIGGER WIRES COULD NOT BE PULLED OUT. THEY USED AS MUCH FORCE AS THEY COULD USE. THEY THEN INTENTIONALLY BROKE APART THE DEVICE TO GET AHOLD OF THE WIRES TO RELEASE THE GRAFT FROM THE DELIVERY SYSTEM. WHILE RETRACTING THE WIRES, THE GRAFT WAS PUSHED BACK OUT OF PLACE BY BLOOD FLOW FORCES. IT WAS NOT SITTING CORRECTLY WITHIN THE FIRST DEVICE. ((B)(4)) A THIRD DEVICE (G47470, LOT E3923818) WOULD NOT TRACK UP BECAUSE OF THE WAY THAT THE SECOND DEVICE WAS PLACED. THE PROCEDURE WAS THEN ABORTED. PATIENT OUTCOME: ACCORDING TO THE INITIAL REPORTER, THE PATIENT DID EXPERIENCE AN ADVERSE EFFECTS DUE TO THIS OCCURRENCE. THE PATIENT LOST 1.5 UNITS OF BLOOD AND DID NOT ACHIEVE PROXIMAL SEAL. UNKNOWN IF THE PATIENT DID REQUIRE AN ADDITIONAL
Patient problems: Hemorrhage/Blood Loss/Bleeding
MAUDE report 13534327 ↗InjuryJan 27, 2022Physical Resistance/Sticking; Physical Resistance/Sticking
DESCRIPTION OF EVENT ACCORDING TO THE INITIAL REPORTER: PT CAME IN EMERGENTLY DUE TO RUPTURE. ON (B)(6) 2022 ((B)(4)) THE FIRST DEVICE ((B)(4), LOT E4201640) DID NOT LAND IN THE RIGHT PLACE DUE TO OPERATOR ERROR. A LACK OF UPWARD FORCE IN HOLDING THE DEVICE INTO POSITION CAUSED THE PROBLEM. ((B)(4)) THEY HAD TO USE SECOND DEVICE ((B)(4), LOT E4202793) BECAUSE THE FIRST DEVICE WAS NOT IN THE PROPER PLACE. WHEN THEY TRIED TO USE THE SECOND DEVICE, THE TRIGGER WIRES COULD NOT BE PULLED OUT. THEY USED AS MUCH FORCE AS THEY COULD USE. THEY THEN INTENTIONALLY BROKE APART THE DEVICE TO GET AHOLD OF THE WIRES TO RELEASE THE GRAFT FROM THE DELIVERY SYSTEM. WHILE RETRACTING THE WIRES, THE GRAFT WAS PUSHED BACK OUT OF PLACE BY BLOOD FLOW FORCES. IT WAS NOT SITTING CORRECTLY WITHIN THE FIRST DEVICE. ((B)(4)) A THIRD DEVICE ((B)(4), LOT E3923818) WOULD NOT TRACK UP BECAUSE OF THE WAY THAT THE SECOND DEVICE WAS PLACED. THE PROCEDURE WAS THEN ABORTED. PATIENT OUTCOME: ACCORDING TO THE INITIAL REPORTER, THE PATIENT DID EXPERIENCE AN ADVERSE EFFECTS DUE TO THIS OCCURRENCE. THE PATIENT LOST 1.5 UNITS OF BLOOD AND DID NOT ACHIEVE PROXIMAL SEAL. UNKNOWN IF THE PATIENT DID REQUIRE AN ADDITIONAL PROCEDU
Patient problems: Hemorrhage/Blood Loss/Bleeding
MAUDE report 13368796 ↗
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page